MIRO News and Press, Miromatrix Medical Inc. From 03/31/23

2023-03-31 16:06:20 ET Miromatrix Medical press release ( NASDAQ: MIRO ): Q4 GAAP EPS of -$0.33 beats by $0.06 . Revenue of $0.93M (-88.4% Y/Y) beats by $0.93M . For further details see: Miromatrix Medical GAAP EPS of -$0.33 beats by $0.06, revenue of $0....

EDEN PRAIRIE, Minn., March 31, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today reported fourth quarter and full year 2022 financial...

EDEN PRAIRIE, Minn., March 15, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that the Company will report financ...

2023-03-08 12:54:43 ET Gainers: Kimball International ( KBAL ) +83% . Arlo Technologies ( ARLO ) +45% . Diversey ( DSEY ) +37% . Maxeon ( MAXN ) +32% . LifeStance ( LFST ) +26% . Mesoblast ( MESO ) +26% . Vertex (...

2023-03-08 10:06:57 ET Gainers: Fresh Tracks Therapeutics ( FRTX ) +42% . LifeStance Health Group ( LFST ) +24% . Assure Holdings ( IONM ) +19% . Mesoblast ( MESO ) +19% . Treace Medical Concepts ( TMCI ) +17% . Losers: ...

2023-03-08 08:46:06 ET Intelligent Bio Solutions ( INBS ) -48% on proposed public offering . Castor Maritime ( CTRM ) -36% . Miromatrix Medical ( MIRO ) -32% on pricing $10M stock offering . United Natural Foods ( UNFI ) -22% on Q2...

2023-03-08 04:02:20 ET Miromatrix Medical ( NASDAQ: MIRO ) has priced an underwritten public offering of 6.25M shares of its common stock at a price to the public of $1.60/share, for expected gross proceeds to be $10.0M. Offering is expected to close on March 10, 2023. ...

EDEN PRAIRIE, Minn., March 07, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced the pr...

2023-03-07 16:47:44 ET Miromatrix Medical ( NASDAQ: MIRO ) has commenced an underwritten public offering of shares of its common stock. Underwriters have a 30-day option to purchase up to an additional 15% of the shares of its common stock. The offering is subject to ...

EDEN PRAIRIE, Minn., March 07, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that i...